Francis Medical Secures J&J Funding to Expand Vanquish
Maple Grove, Minnesota, United States, November 10, 2026 Francis Medical, Inc., a medical technology company specializing in minimally invasive...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Maple Grove, Minnesota, United States, November 10, 2026 Francis Medical, Inc., a medical technology company specializing in minimally invasive...
Milpitas, California, August 4, 2026 Galaxy Therapeutics has announced that its SEALâ„¢ Embolization System has received CE Mark certification...
BOSTON, June 23, 2026 CereVasc, Inc. has completed patient enrollment in its pivotal STRIDE clinical trial, marking a major...
PEACHTREE CORNERS, Ga., June 2026 Guided Therapeutics, Inc. announced the submission of its Premarket Approval (PMA) clinical report to...
MILPITAS, CALIFORNIA, April 27, 2026 Galaxy Therapeutics has announced the submission of the final module of its Premarket Approval...
WHITE BEAR LAKE, MINNESOTA, UNITED STATES — February 17, 2026 Envoy Medical announced that enrollment in its pivotal clinical...
